The federal government is developing Canada’s first long-term research and pandemic preparedness strategy that will include a new Centre for Pandemic Preparedness and Health Emergencies Research. Ottawa has provided nearly $1 million to the Canadian Institutes of Health Research to lead its development.
Person: Paul Hodgson
Feds invest $887 million to ensure reliable vaccine supply for COVID-19, other pandemics
The federal government’s investment of $887 million make Canada self-sufficient in manufacturing vaccines against COVID-19 and future pandemics, say medical and other experts. Along with Canadian-led vaccine development, Ottawa is investing in a network of small-scale vaccine manufacturing facilities that together will be able to produce enough vaccine for Canada’s population during pandemics.
VIDO-InterVac in Saskatchewan fielding massive demand for testing of COVID-19 vaccines and therapeutics
One of the largest “containment Level 3” facilities in the world, University of Saskatchewan’s Vaccine and Infectious Disease Organization – International Vaccine Centre (VIDO-InterVac) in Saskatoon is receiving daily requests from researchers, companies and governments to test COVID-19 vaccines and therapies.
Canada needs small-scale vaccine manufacturing to support research, and help save human and animal lives
The lack of affordable small-scale manufacturing has been a persistent challenge for Canadian researchers, and a gap in the country’s biomedical landscape.
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...